Company page

Acrivon Therapeutics, Inc.

Acrivon Therapeutics, Inc. is a public company traded under the ticker ACRV in the American market. The company has a market capitalization of approximately $68.5 million. Acrivon focuses on developing innovative therapies to improve patient outcomes in various medical conditions.